MEDROXYPROGESTERONE ACETATE (DEPO-PROVERA) VS HYDROXYPROGESTERONE CAPROATE (DELALUTIN) IN WOMEN WITH METASTATIC ENDOMETRIAL ADENOCARCINOMA

被引：0
|
作者：
PIVER, MS [1 ]
BARLOW, JJ [1 ]
LURAIN, JR [1 ]
BLUMENSON, LE [1 ]
机构：
[1] NEW YORK STATE DEPT HLTH,ROSWELL PK MEM INST,DEPT BIOSTAT,BUFFALO,NY 14263
来源：
CANCER | 1980年 / 45卷 / 02期
关键词：
D O I：
10.1002/1097-0142(19800115)45:2<268::AID-CNCR2820450211>3.0.CO;2-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：268 / 272
页数：5
相关论文
共 28 条
  • [21] A prospective, multicenter randomized study of oral contraceptive versus Depo-Provera for the prevention of endometrial cancer in women with Lynch syndrome
    Lu, K.
    Chen, L.
    Lynch, H.
    Munsell, M.
    Cornelison, T.
    Boyd-Rogers, S.
    Rubin, M.
    Daniels, M.
    Loose, D.
    Broaddus, R.
    GYNECOLOGIC ONCOLOGY, 2010, 116 (03) : S4 - S5
  • [22] Longitudinal study of depot medroxyprogesterone acetate (Depo-Provera®) effects on bone health in adolescents:: study design, population characteristics and baseline bone mineral density
    Johnson, Christine C.
    Burkman, Ronald T.
    Gold, Melanie A.
    Brown, Robert T.
    Harel, Zeev
    Bruner, Ann
    Stager, Margaret
    Bachrach, Laura K.
    Hertweck, S. Paige
    Nelson, Anita L.
    Nelson, Dorothy A.
    Coupey, Susan M.
    McLeod, Alison
    Bone, Henry G.
    CONTRACEPTION, 2008, 77 (04) : 239 - 248
  • [23] A PROSPECTIVE-STUDY OF ADOLESCENTS WHO CHOOSE AMONG LEVONORGESTREL IMPLANT (NORPLANT), MEDROXYPROGESTERONE ACETATE (DEPO-PROVERA), OR THE COMBINED ORAL-CONTRACEPTIVE PILL AS CONTRACEPTION
    CROMER, BA
    SMITH, RD
    BLAIR, JM
    DWYER, J
    BROWN, RT
    PEDIATRICS, 1994, 94 (05) : 687 - 694
  • [24] Comparison of the effects of the levonorgestrel-releasing intrauterine system (Mirena®) and depot-medroxyprogesterone acetate (Depo-Provera®) on subendometrial microvascularisation and uterine artery blood flow
    Dane, Banu
    Akca, Aysu
    Dane, Cem
    Evcimen, Serap
    Cetin, Ahmet
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2009, 14 (03): : 240 - 244
  • [25] PLASMA-LEVELS OF MEDROXYPROGESTERONE ACETATE (MPA), SEX-HORMONE BINDING GLOBULIN, GONADAL-STEROIDS, GONADOTROPINS AND PROLACTIN IN WOMEN DURING LONG-TERM USE OF DEPO-MPA (DEPO-PROVERA) AS A CONTRACEPTIVE AGENT
    JEPPSSON, S
    GERSHAGEN, S
    JOHANSSON, EDB
    RANNEVIK, G
    ACTA ENDOCRINOLOGICA, 1982, 99 (03): : 339 - 343
  • [26] Prospective Multicenter Randomized Intermediate Biomarker Study of Oral Contraceptive versus Depo-Provera for Prevention of Endometrial Cancer in Women with Lynch Syndrome
    Lu, Karen H.
    Loose, David S.
    Yates, Melinda S.
    Nogueras-Gonzalez, Graciela M.
    Munsell, Mark F.
    Chen, Lee-may
    Lynch, Henry
    Cornelison, Terri
    Boyd-Rogers, Stephanie
    Rubin, Mary
    Daniels, Molly S.
    Conrad, Peggy
    Milbourne, Andrea
    Gershenson, David M.
    Broaddus, Russell R.
    CANCER PREVENTION RESEARCH, 2013, 6 (08) : 774 - 781
  • [27] Depot medroxyprogesterone acetate (Depo-Provera® 150 mg; DMPA-IM) and bone mineral density in adolescents:: Study design, population characteristics, and baseline bone mineral density
    Johnson, C
    Burkman, T
    Gold, M
    Brown, R
    Harel, Z
    Bruner, A
    Stager, M
    Bachrach, L
    Hertweck, P
    Nelson, A
    Nelson, D
    Coupey, M
    Bone, H
    BONE, 2005, 36 : S62 - S63
  • [28] Letter in response to Levonorgestrel-releasing intrauterine system (Mirena®) and Depot medroxyprogesterone acetate (Depo-Provera) as long-term maintenance therapy for patients with moderate and severe endometriosis: a randomised trial by Wong AYK, Tang LCH, Chin RKH Aust N Z J Obstet Gynaecol 2010; 50 (3): 273-279
    Basu, Abhijit
    Haran, Mano
    Nair, Anil
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2011, 51 (01): : 97 - 98
123